In randomized controlled clinical trials, the confounding of the treatment with other factors (sex, age, other patient characteristics) at baseline is of crucial importance as well as maintaining the integrity of the treatment during the trial. However, an important uncontrolled factor violating the integrity of the treatment is patient behaviour, especially in response to his … Continue reading Modelling of coping strategies as a missed opportunity in drug development